Back
Medicenna Therapeutics Corp. 10K Form
Sell
12
MDNA.TO
Medicenna Therapeutics Corp.
Last Price:
$0.94
Seasonality Move:
-1.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MDNA.TO News And Ratings
See the #1 stock for the next 7 days that we like better than MDNA.TO
MDNA.TO Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-4.9M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.12 |
| Price / Book: | 7.66 |
Profitability
| EPS (TTM): | -0.16950 |
|---|---|
| Net Income (TTM): | $-13.8M |
| Gross Margin: | $-55K |
| Return on Equity: | -84.77% |
| Return on Assets: | -51.41% |
Medicenna Therapeutics Corp. Earnings Forecast
Key Medicenna Therapeutics Corp. Financial Ratios
-
Per Share Earnings over the last 11 years have been positive in 4 years.
Medicenna Therapeutics Corp. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | TSX |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MDNA.TO |
| CUSIP: | 58490H |
| Website: | medicenna.com |
Debt
| Debt-to-Equity Ratio: | 0.01 |
|---|---|
| Current Ratio: | 4.01 |
| Quick Ratio: | 3.53 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MDNA.TO Technical Analysis vs Fundamental Analysis
Sell
12
Medicenna Therapeutics Corp. (MDNA.TO)
is a Sell
Is Medicenna Therapeutics Corp. a Buy or a Sell?
-
Medicenna Therapeutics Corp. stock is rated a SellThe current Medicenna Therapeutics Corp. [MDNA.TO] share price is $0.94. The Score for MDNA.TO is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.